Eva Magiros, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1720a Medical Park Dr, Suite 340, Biloxi, MS 39532 Phone: 228-392-7429 Fax: 228-396-3830 |
Paul E Mullen, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1720a Medical Park Dr, Suite 340, Biloxi, MS 39532 Phone: 228-392-7429 Fax: 228-396-3830 |
Dr. Gilberto Patino, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 301 Fisher Street, Cardiology Clinic, Biloxi, MS 39534 Phone: 228-376-3775 Fax: 228-376-1050 |
Antoine Rizk, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1720a Medical Park Dr, Suite 340, Biloxi, MS 39532 Phone: 228-392-7429 Fax: 228-396-3830 |
Dr. Narayana C Swamy, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 400 Veterans Ave, Biloxi, MS 39531 Phone: 228-523-5470 Fax: 228-523-4971 |
Jack W Brand Jr., MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1720a Medical Park Dr, Suite 340, Biloxi, MS 39532 Phone: 228-392-7429 Fax: 228-396-3830 |
News Archive
More than 20% of pregnant women beginning anti-HIV treatment were prescribed an antiretroviral treatment that did not meet federal guidelines for use during pregnancy, according to an analysis funded by the National Institutes of Health.
Caprion - HistoGeneX announced today that the company is launching a molecular PCR testing service for identifying patients with COVID-19.
According to a strategic document published by the World Bank (2006), malnutrition leads to indirect losses in productivity from poor cognitive development and schooling.
After months of discussion and debate, the House has passed its version of health care reform. But as many observers, including me, have already noted, health care reform has primarily become health insurance reform over the course of the year (Gail Wilensky, 11/12).
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
› Verified 2 days ago